Cargando…
Association between Dupilumab and Conjunctivitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Conjunctivitis is commonly reported in dupilumab users with atopic dermatitis (AD), and few studies have compared the risk of conjunctivitis among patients with different indications. This study aimed to investigate the association between dupilumab and conjunctivitis in various diseases. The protoc...
Autores principales: | Lin, Tzu-Yi, Wang, Ching-Ya, Wang, Fang-Ying, Kang, Eugene Yu-Chuan, Hwang, Yih-Shiou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145140/ https://www.ncbi.nlm.nih.gov/pubmed/37111517 http://dx.doi.org/10.3390/pharmaceutics15041031 |
Ejemplares similares
-
Conjunctivitis in dupilumab clinical trials
por: Akinlade, B., et al.
Publicado: (2019) -
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
por: Bansal, Ashish, et al.
Publicado: (2021) -
Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020) -
Topical treatment of dupilumab-associated refractory conjunctivitis and keratitis
por: Di Staso, Federico, et al.
Publicado: (2022) -
A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
por: Agnihotri, Gaurav, et al.
Publicado: (2019)